Infection control practices and the pregnant health care worker

Pediatric Infectious Disease Journal

Volumn 18, Issue 1, 1999, Pages 18-22

  Mirza, Ayesha ^a   Wyatt, Marsha ^a   Begue, Rodolfo E ^a,b  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL   (United States)

Author keywords

Nosocomial infection; Pregnant health care worker; Prophylaxis

Indexed keywords

CHICKENPOX; HEALTH CARE PERSONNEL; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HIGH RISK POPULATION; HOSPITAL INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNIZATION; INFECTION CONTROL; NEISSERIA MENINGITIDIS; NOTE; PREGNANCY; PRIORITY JOURNAL; SCREENING; TUBERCULOSIS;

FEMALE; HEALTH PERSONNEL; HUMANS; INFECTION CONTROL; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

EID: 0032900225     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199901000-00006     Document Type: Note

References (51)

1. Williams WW. Guideline for infection control in hospital personnel. Infect Control 1983;4:326-49.
2. Siegel JD. Risk and exposures for the pregnant health-care worker. In: Olmsted RN, ed. APIC infection control and applied epidemiology: principles and practice. St. Louis: Mosby, 1996;22-1-8.
3. Valenti WM. Infection control and the pregnant health care worker. Nurs Clin North Am 1993;28:673-86.
4. Shortridge-McCauley LA. Reproductive hazards: an overview of exposures to health care workers. AAOHN J 1995;43:614-21.
5. Voltra EM, Rutala WA, Sarubbi FA. Recommendations for pregnant employee interaction with patients having communicable infectious diseases. Am J Infect Control 1983;11: 10-9.
6. Valenti WM. Infection control and the pregnant health care worker. Am J Infect Control 1986;14:20-7.
7. Bolyard EA, Tablan OC, Williams WW, Pearson ML, Shapiro CN, Deitchman SD, and the Hospital Infection Control Practices Advisory Committee. Guideline for infection control in healthcare personnel, 1998. Infect Control Hosp Epidemiol 1998;19:407-63.
8. Centers for Disease Control and Prevention. Immunization of health-care workers. MMWR 1997;46(RR-18).
9. Gardner P, Schaffner W. Immunization of adults. N Engl J Med 1993;328:1252-8.
10. Centers for Disease Control and Prevention. Protection against viral hepatitis: recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR 1990; 39(RR-2).
11. Centers for Disease Control and Prevention. Update on adult immunization: recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR 1991;40(RR-12).
12. Lyznicki JM, Bezman RJ, Genel M. Report of the Council on Scientific Affairs American Medical Association. Immunization of health care workers with varicella vaccine. Infect Control Hosp Epidemiol 1998;19:348-53.
13. Centers for Disease Control and Prevention. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 996;45(RR-11).
14. Huebner RE, Schein MF, Bass JE, Jr. The tuberculin skin test. Clin Infect Dis 1993;17:968-75.
15. Centers for Disease Control and Prevention. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1998; 47(RR-6).
16. Garner JS, Hospital Infection Control Practices Advisory Committee. Guidelines for isolation precautions in hospitals. Infect Control Hosp Epidemiol 1996;17:53-80.
17. American Academy of Pediatrics, Committee on Infectious Diseases. Parvovirus, erythema infectiosum and pregnancy. Pediatrics 1990;85:131-3.
18. Stagno S, Pass R, Cloud G, et al. Primary cytomegalovirus infection in pregnancy: incidence, transmission to fetus, and clinical outcome. JAMA 1986;256:1904-8.
19. Alford CA, Stagno S, Pass RF, Britt WJ. Congenital and perinatal cytomegalovirus infections. Rev Infect Dis 1990;12: S7:45-53.
20. Fowler KB, Stagno S, Pass RF, Britt WJ, Boll TJ, Alford CA. The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. N Engl J Med 1992;326: 663-7.
21. Yow MD, Lakeman AD, Stagno S. Use of restriction enzymes to investigate the source of a primary cytomegalovirus infection in a pediatric nurse. Pediatrics 1982;70:713-6.
22. Kurtzman G, Frickhofen N, Kimball J, Jenkins DW, Nienhuis AW, Young NS. Pure red-cell aplasia of 10 years' duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy. N Engl J Med 1989;321: 519-23.
23. American Academy of Pediatrics, Committee on Infectious Diseases. Use of rivabirin in the treatment of respiratory syncytial virus infection. Pediatrics 1993;92:501-4.
24. The Medical Letter. Safety of antimicrobial drugs in pregnancy. Med Lett 1987;29:61-3.
25. Centers for Disease Control and Prevention. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care facilities, 1994. MMWR 1994;43(RR-13).
26. American Academy of Pediatrics. Tuberculosis. In: Peter, G, ed. 1977 Red Book: Report of the Committee on Infectious Diseases, 24th ed. Elk Grove Village, IL: American Academy of Pediatrics, 1977:541-62.
27. Smego RA, Asperilla MO. Use of acyclovir for varicella pneumonia during pregnancy. Obstet Gynecol 1991;78: 1112-6.
28. Enders G, Miller E, Cradock-Watson J, Bolley I, Ridehalgh M. Consequences of varicella and herpes zoster in pregnancy: prospective study of 1739 cases. Lancet 1994;343:1548-51.
29. Scott LL, Hollier LM, Dias K. Perinatal herpesvirus infections: herpes simplex, varicella and cytomegalovirus. Infect Dis Clin North Am 1997;11:27-53.
30. American Academy of Pediatrics. Varicella-zoster infections. In: Peter, G, ed. 1977 Red Book: Report of the Committee on Infectious Diseases, 24th ed. Elk Grove Village, IL: American Academy of Pediatrics, 1977:573-85.
31. Enders G. Management of varicella-zoster contact and infection in pregnancy using a standardized varicella-zoster ELISA test. Postgrad Med J 1985;61:23-30.
32. Brunell PA. Varicella in pregnancy, the fetus, and the newborn: problems in management. J Infect Dis 1992;166(Suppl 1)S42-7.
33. Andrews EB, Tilson HH, Hurn BAL, Cordero JF. Acyclovir in Pregnancy Registry: an observational epidemiologic approach. Am J Med 1988;85(Suppl 2A):123-9.
34. Wallace MR, Bowler WA, Murray NB, Brodine SK, Oldfield EC III. Treatment of adult varicella with oral acyclovir: a randomized, placebo-controlled trial. Ann Intern Med 1992; 117:358-63.
35. American Academy of Pediatrics, Committee on Infectious Diseases. Meningococcal disease prevention and control strategies for practice-based physicians. Pediatrics 1996;97: 404-11.
36. American Academy of Pediatrics. Meningococcal infections. In: Peter, G, ed. 1977 Red Book: Report of the Committee on Infectious Diseases, 24th ed. Elk Grove Village, IL: American Academy of Pediatrics, 1977:357-62.
37. Gerberding JL, Henderson DK. Management of occupational exposures to bloodborne pathogens: hepatitis B virus, hepatitis C virus, and human immunodeficiency virus. Clin Infect Dis 1992;14:1179-85.
38. Gerberding JL. Management of occupational exposures to blood-borne viruses. N Engl J Med 1995;332:444-51.
39. National Institutes of Health Consensus Development Conference Panel. Statement: management of hepatitis C. Hepatology 1997;26(Suppl 1):S2-10.
40. Lanphear BP, Linnemann CC, Cannon CG, DeRonde MM, Pendy L, Kerley LM. Hepatitis C virus infection in healthcare workers: risk of exposure and infection. Infect Control Hosp Epidemiol 1994;15:745-50.
41. Centers for Disease Control and Prevention. Recommendations for follow-up of health-care workers after occupational exposure to hepatitis C virus. MMWR 1997;46:603-6.
42. Ohto H, Terazawa S, Sasaki N, et al. Transmission of hepatitis C virus from mothers to infants. N Engl J Med 1994;330:744-50.
43. Zein NN. Vertical transmission of hepatitis C: to screen or not to screen. J Pediatr 1997;130:859-61.
44. Lin HH, Kao JH, Hsu HY, et al. Absence of infection in breast-fed infants born to hepatitis C virus-infected mothers. J Pediatr 1995;126:589-91.
45. American Academy of Pediatrics. Hepatitis C. In: Peter, G, ed. 1977 Red Book: Report of the Committee on Infectious Diseases, 24th ed. Elk Grove Village, IL: American Academy of Pediatrics, 1977:260-4.
46. Centers for Disease Control and Prevention. Case-control study of HIV seroconversion in health-care workers after percutaneous exposure to HIV-infected blood: France, United Kingdom, and United States, January 1988-August 1994. MMWR 1995;44:929-33.
47. Centers for Disease Control and Prevention. Public Health Service guidelines for the management of health-care worker exposures to HIV and recommendations for postexposure prophylaxis. MMWR 1998;47(RR-7).
48. Tokars JL, Marcus R, Culver DH, et al. Surveillance of HIV infection and zidovudine use among health care workers after occupational exposure to HIV-infected blood. Ann Intern Med 1993;118:913-9.
49. White A, Andrews E, Eldridge R, et al. Birth outcomes following zidovudine therapy in pregnant women. MMWR 1994;43:409-16.
50. Centers for Disease Control and Prevention. Recommendations of the Public Health Service Task Force on the use of zidovudine to reduce perinatal transmission of human immunodeficiency virus. MMWR Morb Mortal Wkly Rep 1994; 43(RR-11).
51. Centers for Disease Control and Prevention. Public Health Service Task Force recommendations for the use of antiretroviral drugs in pregnant women infected with HIV-1 for maternal health and for reducing perinatal HIV-1 transmission in the United States. MMWR 1998;47(RR-2).